深圳市卫光生物制品股份有限公司 is engaged in the research, production, and sales of blood products, including human serum albumin and intravenous immunoglobulin.

深圳市卫光生物制品股份有限公司

Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.

Shenzhen Weiguang Biological Products Co., Ltd.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 11, 2024 9:15 AM	9ae7c55b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 11, 2024 9:15 AM	82dae29a
crunchbase trigger	general	Nov 27, 2024 12:50 PM	090deccd
crunchbase profile	general
li profile	general	Nov 11, 2024 9:15 AM	6b620d6e
translate crunchbase fundingrounds	general
peers	general	Nov 11, 2024 9:15 AM	56aac4bb
news basic	general	Nov 11, 2024 9:15 AM	0700d0eb
bundesanzeiger	filings
financials download nd	financials
private financials	financials

0028

COM:SZWG

深圳市卫光生物制品股份有限公司

Last Close

26.54

14/02 07:04

Market Cap

6.41B

Beta: -

Volume Today

1.84M

Avg: -